CClinicalTrials.gg
CompletedNCT01426581E-TRaINUpdated Nov 19, 2019Results posted

Effectiveness of Interventions to Teach Respiratory Inhaler Technique (E-TRaIN)

An interventional study of Teach-To-Goal and Brief Intervention in Asthma and Chronic Obstructive Pulmonary Disease (COPD), sponsored by University of Chicago. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-11-19.

Sponsored by University of Chicago · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to evaluate the relative effectiveness of two different ways to teach subjects while hospitalized how to use respiratory inhalers and to follow-up after discharge home from the hospital to determine durability of the education.

Teach-to-Goal (TTG) education employs instruction followed by patient "teach-back," then repeated cycles of learning and assessment until a skill is mastered. By contrast, Brief Intervention (BI) education only consists of providing the patient with verbal and written instruction.

The investigators hypothesize that hospital-based TTG compared to BI increases a patient's ability to retain instructions on respiratory inhaler technique. The investigators will test this hypothesis separately for the MDI and Diskus® devices after discharge.

Read the detailed description

Respiratory inhalers are often used incorrectly by patients with obstructive lung disorders (including patients hospitalized with exacerbations of asthma or chronic obstructive pulmonary disease (COPD). As the mainstay of bronchodilator and anti-inflammatory therapy in patients with OLD, the implication of this difficulty with self-management is that patients are at risk for under-treatment and worse health outcomes. Several factors are thought to contribute to poor self-management skills, particularly inadequate patient education at healthcare encounters and inadequate patient health literacy. However, the most effective strategy to instruct patients about respiratory inhaler use in hospital settings is unclear, particularly in populations enriched with inadequate health literacy.

Therefore, the overall goal of this study is to evaluate the relative effectiveness of two hospital-based educational interventions: Teach-To-Goal (TTG, iterative cycles of demonstration-based education and assessment) versus Brief Intervention (BI, one-time set of verbal instructions) on the durability of instructions provided in the hospital and its effect on clinical outcomes (e.g., respiratory events and/or death), post hospital discharge. The investigators also plan to evaluate whether the relative effectiveness of TTG vs. BI varies by level of health literacy. The objectives of this proposal are to conduct a study in adults hospitalized with asthma/COPD to 1) to evaluate the relative effectiveness of hospital-based TTG versus BI on patients' ability to retain instruction about the correct use of MDI and Diskus® devices after discharge home and 2) To determine the relative effectiveness of TTG compared to BI for patients with less-than-adequate health literacy compared to those with adequate health literacy. These data will inform the development of a larger, multi-center clinical trial.

02

Conditions studied

  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)

Keywords

  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Pulmonary Disease, Chronic Obstructive
  • Lung Disease, Obstructive
  • Self-management
  • Health Literacy
03

In context

Lung Diseases

3,303 studies on the registry are indexed under Lung Diseases; 355 are open to participants now.

This study's enrollment of 120 is above the median of 72 across 2,118 interventional studies indexed under Lung Diseases.

Browse Lung Diseases studies →

Lead sponsor

University of Chicago is the lead sponsor of 907 studies on the registry; 182 are open to participants now.

Of its 99 completed or terminated interventional studies of FDA-regulated products, 68 (69%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • 18 years and older
  • Admitting diagnosis of asthma or COPD
  • Physician- diagnosed asthma, asthma/COPD, or COPD. We will enroll patients even if the primary reason for admission is not asthma or COPD (e.g., patients admitted for heart failure, but with a physician diagnosis of COPD are eligible)
  • Patient will be discharged home on a Metered Dose Inhaler (MDI; e.g., albuterol)

Exclusion criteria

Exclusion Criteria:

  • Currently in an intensive care unit
  • Physician declines to provide consent
  • Patient unable to provide consent (e.g., history of cognitive impairment, unable to understand English) or declines to provide consent
  • Previous participant in this study
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
120 participants (actual)

Study arms

  • Experimental
    Educational Intervention A

    Intervention: Teach to Goal

    Behavioral: Teach-To-Goal

  • Experimental
    Educational Intervention B:

    Brief Intervention

    Behavioral: Brief Intervention

Interventions

  • BehavioralTeach-To-Goal

    Participants observe a demonstration on the use of each inhaler, with corresponding verbal step-by-step instructions (demonstration, verbal instruction), then participants 'teachback" or re-demonstrate the steps; cycles are repeated are read step-by-step instructions (verbal instructions) for each respective inhaler (Metered Dose Inhaler +/- Diskus), and receive a copy of these instructions with images depicting the steps (written instructions)

  • BehavioralBrief Intervention

    Participants are read step-by-step instructions (verbal instructions) for each respective inhaler (Metered Dose Inhaler +/- Diskus), and receive a copy of these instructions with images depicting the steps (written instructions)

06

What researchers measure

Primary outcomes

  1. Percentage of Participants With MDI Misuse From Baseline to 30 Days Post-Discharge

    To evaluate the relative effectiveness of hospital-based TTG versus BI on patients' ability to retain instruction about the correct use of MDI Devices one month after discharge home.

    Time frame: 1 month

Secondary outcomes

  1. Role of Health Literacy - Number of Less-Than-Adequate Health Literacy Participants With 30 Days Post Discharge Acute-Care Events

    To determine the relative effectiveness of TTG compared to BI for patients with less-than-adequate health literacy using self-reported acute-care events 30 days post discharge. To measure less-than-adequate health literacy, the investigators administered the Short Test of Functional Health Literacy in Adults, a validated tool to assess whether a participant has adequate, marginal, or inadequate health literacy. Less-than-adequate included marginal and inadequate health literacy.

    Time frame: 1 month

  2. Number of Participants With Self-Efficacy

    This is a self-reported measure of how confident a participant is on how well they use their metered dose inhaler.

    Time frame: 1 month

  3. Symptom Control

    Symptom control will be assessed using interviewer-administered surveys. Using the Borg Dyspnea Scale, a validated Scale from 0 - 20 where 20 is maximal dyspnea, we took the difference between the the 30 day follow-up self reported shortness of breath from baseline to see if there was improvement in symptom control.

    Time frame: 1 month

  4. Number of Participants With Acute Care Events 30 Days Post Discharge

    Exacerbation/acute care events within one month of hospital discharge

    Time frame: 1 month

07

Results

Posted Oct 29, 2019

Participant flow

Participants were randomized into TTG or BI between September 2011 and February 2013. Of the 120 participants, 100 were enrolled at hospital #1 and 20 were enrolled from hospital #2.

Participant flow — Overall Study
MilestoneTeach To GoalBrief Intervention:
Started6258
Completed6258
Not completed00

Outcome measures

PrimaryPercentage of Participants With MDI Misuse From Baseline to 30 Days Post-Discharge

To evaluate the relative effectiveness of hospital-based TTG versus BI on patients' ability to retain instruction about the correct use of MDI Devices one month after discharge home.

Time frame:
1 month
Reported as:
Number · percentage
Percentage of Participants With MDI Misuse From Baseline to 30 Days Post-Discharge
percentageTeach to GoalBrief Intervention
Misuse at Baseline9284
Misuse at 30 days post-discharge1160
SecondaryRole of Health Literacy - Number of Less-Than-Adequate Health Literacy Participants With 30 Days Post Discharge Acute-Care Events

To determine the relative effectiveness of TTG compared to BI for patients with less-than-adequate health literacy using self-reported acute-care events 30 days post discharge. To measure less-than-adequate health literacy, the investigators administered the Short Test of Functional Health Literacy in Adults, a validated tool to assess whether a participant has adequate, marginal, or inadequate health literacy. Less-than-adequate included marginal and inadequate health literacy.

Time frame:
1 month
Reported as:
Count of participants · Participants
Role of Health Literacy - Number of Less-Than-Adequate Health Literacy Participants With 30 Days Post Discharge Acute-Care Events
ParticipantsTeach To GoalBrief Intervention
Role of Health Literacy - Number of Less-Than-Adequate Health Literacy Participants With 30 Days Post Discharge Acute-Care Events27
SecondaryNumber of Participants With Self-Efficacy

This is a self-reported measure of how confident a participant is on how well they use their metered dose inhaler.

Time frame:
1 month
Reported as:
Count of participants · Participants
Number of Participants With Self-Efficacy
ParticipantsTeach To GoalBrief Intervention:
Number of Participants With Self-Efficacy4938
SecondarySymptom Control

Symptom control will be assessed using interviewer-administered surveys. Using the Borg Dyspnea Scale, a validated Scale from 0 - 20 where 20 is maximal dyspnea, we took the difference between the the 30 day follow-up self reported shortness of breath from baseline to see if there was improvement in symptom control.

Time frame:
1 month
Reported as:
Mean · units on a scale
Symptom Control
units on a scaleTeach To GoalBrief Intervention:
Symptom Control-1.69 ± 2.75-1.43 ± 2.59
SecondaryNumber of Participants With Acute Care Events 30 Days Post Discharge

Exacerbation/acute care events within one month of hospital discharge

Time frame:
1 month
Reported as:
Count of participants · Participants
Number of Participants With Acute Care Events 30 Days Post Discharge
ParticipantsTeach To GoalBrief Intervention:
Number of Participants With Acute Care Events 30 Days Post Discharge919

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Educational Intervention A—0/62 (0%)0/62 (0%)
Educational Intervention B:—0/58 (0%)0/58 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Teach To GoalBrief InterventionTotal
<=18 years000
Between 18 and 65 years5451105
>=65 years8715
Sex: Female, Male
Sex: Female, Male(Participants)Teach To GoalBrief InterventionTotal
Female474188
Male151732
08

Study locations

1 site
  • University of Chicago
    Chicago, Illinois 60637, United States
09

References and documents

Publications

  • Press VG, Arora VM, Trela KC, Adhikari R, Zadravecz FJ, Liao C, Naureckas E, White SR, Meltzer DO, Krishnan JA. Effectiveness of Interventions to Teach Metered-Dose and Diskus Inhaler Techniques. A Randomized Trial. Ann Am Thorac Soc. 2016 Jun;13(6):816-24. doi: 10.1513/AnnalsATS.201509-603OC. PubMed 26998961 ↗
10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 19, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT01426581
Lead sponsor
University of Chicago
Responsible party
Sponsor
First posted
Aug 31, 2011
Start date
Aug 2011
Primary completion
Dec 2012
Completion
Feb 2013
Results posted
Oct 29, 2019
Last update
Nov 19, 2019

Study contacts

Valerie G Press, MD, MPH
principal investigator · University of Chicago

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion